المؤلفون: Matos, GM, Garcia-Teodoro, B, Martins, CP, Schmitt, P, Guzman, F, de Freitas, ACO, Stoco, PH, Ferreira, FA, Stadnik, MJ, Robl, D, Perazzolo, LM, Rosa, RD

المصدر: Biomolecules. 13(1)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:151818594

المؤلفون: Warren, Robert, Farkas, C, Martins, CP, Escobar, D, Hepp, MI, Castro, AF, Evan, G, Gutiérrez, JL, Donner, DB, Pincheira, R

URL الوصول: https://escholarship.org/uc/item/7k75j1q8

المؤلفون: Rubert J, León N, Sáez C, Martins CP, Godula M, Yusà V, Mañes J, Soriano JM, Soler C

المصدر: ANALYTICA CHIMICA ACTA
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica

مصطلحات موضوعية: Liquid chromatography-high resolution mass spectrometry, Human milk, Sample preparation, food and beverages, Mycotoxins, Orbitrap, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7d4a285aad45d8d90758abd395d5bf5e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4915

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Dias HS; Research and Innovation Vice-Direction, Sergio Arouca National School of Public Health, Rio de Janeiro, RJ, Brazil., Pereira AMM; Department of Health Planning and Administration, Sergio Arouca National School of Public Health, Rio de Janeiro, Rio de Janeiro, Brazil., Nunes EFPA; Department of Collective Health, Londrina State University, Londrina, Paraná, Brazil., Martins CP; Department of Collective Health, Londrina State University, Londrina, Paraná, Brazil., Castilho M; Department of Collective Health, Londrina State University, Londrina, Paraná, Brazil., Mendonça FF; Department of Collective Health, Londrina State University, Londrina, Paraná, Brazil., de Lima LD; Department of Health Planning and Administration, Sergio Arouca National School of Public Health, Rio de Janeiro, Rio de Janeiro, Brazil.

المصدر: PloS one [PLoS One] 2024 Aug 09; Vol. 19 (8), pp. e0308754. Date of Electronic Publication: 2024 Aug 09 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Primary Health Care*/economics , Healthcare Financing* , Resource Allocation*/economics , Politics*, Humans

عنوان ترانسليتريتد: A saúde indígena na atenção especializada: perspectiva dos profissionais de saúde em um hospital de referência no Mato Grosso do Sul, Brasil.

المؤلفون: Casagranda F; Universidade Federal da Grande Dourados, Dourados, Brasil., Luz VG; Universidade Federal da Grande Dourados, Dourados, Brasil., Martins CP; Universidade Federal da Grande Dourados, Dourados, Brasil., Dias-Scopel RP; Instituto Leônidas & Maria Deane, Fundação Oswaldo Cruz, Manaus, Brasil., Fernandes R; Universidade Federal da Grande Dourados, Dourados, Brasil., Fonseca W; Universidade Federal da Grande Dourados, Dourados, Brasil.; Empresa Brasileira de Serviços Hospitalares, Dourados, Brasil.

المصدر: Cadernos de saude publica [Cad Saude Publica] 2024 Jul 29; Vol. 40 (6), pp. e00094622. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Escola Nacional De Saúde Pública, Fundação Oswaldo Cruz Country of Publication: Brazil NLM ID: 8901573 Publication Model: eCollection Cited Medium: Internet ISSN: 1678-4464 (Electronic) Linking ISSN: 0102311X NLM ISO Abbreviation: Cad Saude Publica Subsets: MEDLINE

مواضيع طبية MeSH: Health Services, Indigenous* , Health Personnel* , Attitude of Health Personnel*, Humans ; Brazil ; Cross-Sectional Studies ; Male ; Female ; Surveys and Questionnaires ; Adult ; Indians, South American/statistics & numerical data ; Middle Aged ; Young Adult

المؤلفون: Hardaker EL; Oncology R&D, AstraZeneca, Cambridge, UK., Sanseviero E; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Karmokar A; Oncology R&D, AstraZeneca, Cambridge, UK., Taylor D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Milo M; Oncology R&D, AstraZeneca, Cambridge, UK., Michaloglou C; Oncology R&D, AstraZeneca, Cambridge, UK., Hughes A; Oncology R&D, AstraZeneca, Cambridge, UK., Mai M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., King M; Oncology R&D, AstraZeneca, Cambridge, UK., Solanki A; Oncology R&D, AstraZeneca, Cambridge, UK., Magiera L; Oncology R&D, AstraZeneca, Cambridge, UK., Miragaia R; Oncology R&D, AstraZeneca, Cambridge, UK., Kar G; Oncology R&D, AstraZeneca, Cambridge, UK., Standifer N; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Tempest Therapeutics, Brisbane, CA, USA., Surace M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Gill S; Oncology R&D, AstraZeneca, Cambridge, UK., Peter A; Oncology R&D, AstraZeneca, Cambridge, UK., Talbot S; Oncology R&D, AstraZeneca, Cambridge, UK., Tohumeken S; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Fryer H; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mostafa A; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mulgrew K; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Lam C; Oncology R&D, AstraZeneca, Cambridge, UK., Hoffmann S; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Sutton D; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Carnevalli L; Oncology R&D, AstraZeneca, Cambridge, UK., Calero-Nieto FJ; Oncology R&D, AstraZeneca, Cambridge, UK., Jones GN; Oncology R&D, AstraZeneca, Cambridge, UK., Pierce AJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Crescendo Biologics Limited, Cambridge, UK., Wilson Z; Oncology R&D, AstraZeneca, Cambridge, UK., Campbell D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Nyoni L; Oncology R&D, AstraZeneca, Cambridge, UK., Martins CP; Oncology R&D, AstraZeneca, Cambridge, UK., Baker T; CPSS AST, AstraZeneca, Cambridge, UK., Serrano de Almeida G; CPSS AST, AstraZeneca, Cambridge, UK., Ramlaoui Z; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Bidar A; CPSS, Imaging, AstraZeneca, Gothenburg, Sweden., Phillips B; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Boland J; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Iyer S; Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett JC; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Loembé AB; Early Clinical Development, AstraZeneca, Oss, the Netherlands., Fuchs SY; Department of Biomedical Sciences, School of Veterinary Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA., Duvvuri U; UPMC Department of Otolaryngology and UPMC Hillman Cancer Center, 200 Lothrop St. Suite 500, Pittsburg, PA, 15213, USA., Lou PJ; National Taiwan University Hospital, No. 7, Chung Shan S. Rd. (Zhongshan S. Rd.), Zhongzheng Dist., Taipei City, 10002, Taiwan., Nance MA; VA Pittsburgh Healthcare System, University Drive C, Pittsburg, PA, 15240, USA., Gomez Roca CA; Institut Claudius Regaud-Cancer Comprehensive Center, 1 Avenue Irene Joliot-Curie, IUCT-O, Toulouse, 31059 Cedex 9, France., Cadogan E; Oncology R&D, AstraZeneca, Cambridge, UK., Critichlow SE; Oncology R&D, AstraZeneca, Cambridge, UK., Fawell S; Oncology R&D, AstraZeneca, Boston, MA, USA., Cobbold M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Dean E; Oncology R&D, AstraZeneca, Cambridge, UK., Valge-Archer V; Oncology R&D, AstraZeneca, Cambridge, UK., Lau A; Oncology R&D, AstraZeneca, Cambridge, UK., Gabrilovich DI; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. dmitry.gabrilovich@astrazeneca.com., Barry ST; Oncology R&D, AstraZeneca, Cambridge, UK. simon.t.barry@astrazeneca.com.

المصدر: Nature communications [Nat Commun] 2024 Feb 24; Vol. 15 (1), pp. 1700. Date of Electronic Publication: 2024 Feb 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes* , Neoplasms* , Indoles* , Morpholines* , Pyrimidines* , Sulfonamides*, Humans ; Animals ; Mice ; B7-H1 Antigen ; Tumor Microenvironment ; Cell Line, Tumor ; Immunotherapy ; Disease Models, Animal ; Ataxia Telangiectasia Mutated Proteins

المؤلفون: Oliveira FAF; Graduate Program in Rehabilitation Sciences, Centro Universitário Augusto Motta - UNISUAM, Rio de Janeiro, Brazil., Martins CP; Graduate Program in Rehabilitation Sciences, Centro Universitário Augusto Motta - UNISUAM, Rio de Janeiro, Brazil., de Oliveira LAS; Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro - IFRJ, Rio de Janeiro, Brazil., Rodrigues EC; Graduate Program in Rehabilitation Sciences, Centro Universitário Augusto Motta - UNISUAM, Rio de Janeiro, Brazil.; Instituto D'Or de Ensino e Pesquisa - IDOR, Rio de Janeiro, Brazil., Ferreira AS; Graduate Program in Rehabilitation Sciences, Centro Universitário Augusto Motta - UNISUAM, Rio de Janeiro, Brazil., Lemos T; Graduate Program in Rehabilitation Sciences, Centro Universitário Augusto Motta - UNISUAM, Rio de Janeiro, Brazil.

المصدر: Topics in stroke rehabilitation [Top Stroke Rehabil] 2023 Oct; Vol. 30 (7), pp. 663-671. Date of Electronic Publication: 2022 Oct 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9439750 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-5119 (Electronic) Linking ISSN: 10749357 NLM ISO Abbreviation: Top Stroke Rehabil Subsets: MEDLINE

مواضيع طبية MeSH: Posture* , Stroke*/complications, Humans ; Cross-Sectional Studies ; Standing Position ; Postural Balance

المؤلفون: Chakraborty A; AstraZeneca, Cambridge, United Kingdom., Hanson L; AstraZeneca, Cambridge, United Kingdom., Robinson D; AstraZeneca, Cambridge, United Kingdom., Lewis H; AstraZeneca, Cambridge, United Kingdom., Bickerton S; AstraZeneca, Cambridge, United Kingdom., Davies M; AstraZeneca, Cambridge, United Kingdom., Polanski R; AstraZeneca, Cambridge, United Kingdom., Whiteley R; AstraZeneca, Cambridge, United Kingdom., Koers A; AstraZeneca, Cambridge, United Kingdom., Atkinson J; AstraZeneca, Cambridge, United Kingdom., Baker T; AstraZeneca, Cambridge, United Kingdom., Del Barco Barrantes I; AstraZeneca, Cambridge, United Kingdom., Ciotta G; AstraZeneca, Cambridge, United Kingdom., Kettle JG; AstraZeneca, Cambridge, United Kingdom., Magiera L; AstraZeneca, Cambridge, United Kingdom., Martins CP; AstraZeneca, Cambridge, United Kingdom., Peter A; AstraZeneca, Cambridge, United Kingdom., Wigmore E; AstraZeneca, Cambridge, United Kingdom., Underwood Z; AstraZeneca, Cambridge, United Kingdom., Cosulich S; AstraZeneca, Cambridge, United Kingdom., Niedbala M; AstraZeneca, Waltham, Massachusetts., Ross S; AstraZeneca, Cambridge, United Kingdom.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Oct 07; Vol. 21 (10), pp. 1535-1546.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Cysteine*, Cell Line, Tumor ; Glycine/pharmacology ; Humans ; Mutation ; Protein Isoforms ; Xenograft Model Antitumor Assays